The Use of Melatonin by Children: Parents' Perspectives
- PMID: 27568907
- PMCID: PMC5033742
- DOI: 10.5664/jcsm.6198
The Use of Melatonin by Children: Parents' Perspectives
Abstract
Study objectives: To explore the perceptions and experiences of parents whose children were using melatonin.
Methods: A qualitative exploratory study was undertaken using face-to-face semi-structured interviews that were audio recorded and transcribed verbatim. Data was thematically analyzed via open coding and subsequent axial coding. Data collection continued until theoretical saturation occurred.
Results: Eleven interviews with parents of children with a neurodevelopmental disorder were conducted. Each parent perceived melatonin as effective in alleviating their child's sleep disturbance, and in restoring family functioning after many years of hardship and stress. The perceived "naturalness" of melatonin was valued by participants, who tended to favor it over other medications prescribed for sleep. The cost of melatonin was also commented on by every participant; however, all perceived the benefits of melatonin for the child and the family to outweigh the cost burden. When discussing the future, some parents were unsure of whether their child would still be using melatonin; however, others were happy for their child to continue melatonin indefinitely. In addition, many parents expressed a desire for prescribers to have greater knowledge about melatonin, and to acknowledge the positive impact melatonin had had on their lives.
Conclusions: Parents perceive melatonin to be effective in alleviating their child's sleep disturbance and in improving their behavior, as well as restoring family functioning.
Keywords: melatonin; parents' perspectives; qualitative research; sleep disturbances.
© 2016 American Academy of Sleep Medicine
Similar articles
-
Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.Expert Rev Neurother. 2015 Jun;15(6):711-7. doi: 10.1586/14737175.2015.1041511. Epub 2015 May 4. Expert Rev Neurother. 2015. PMID: 25938708
-
Factors associated with melatonin use in child sleep disturbance: A survey of Australian parents.Sleep Med. 2023 Jul;107:330-337. doi: 10.1016/j.sleep.2023.04.026. Epub 2023 May 16. Sleep Med. 2023. PMID: 37295036
-
Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes.J Autism Dev Disord. 2012 Aug;42(8):1729-37; author reply 1738. doi: 10.1007/s10803-011-1418-3. J Autism Dev Disord. 2012. PMID: 22160300 Free PMC article. Clinical Trial.
-
Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis.Arch Dis Child. 2018 Dec;103(12):1155-1162. doi: 10.1136/archdischild-2017-314181. Epub 2018 May 2. Arch Dis Child. 2018. PMID: 29720494
-
[Melatonin for children with insomnia].Ugeskr Laeger. 2018 May 7;180(19):V08170628. Ugeskr Laeger. 2018. PMID: 29761771 Review. Danish.
Cited by
-
Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation.EClinicalMedicine. 2023 Jul 6;61:102048. doi: 10.1016/j.eclinm.2023.102048. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37457117 Free PMC article.
-
Melatonin Treatment for Pediatric Patients with Insomnia: Is There a Place for It?Nat Sci Sleep. 2022 Oct 27;14:1927-1944. doi: 10.2147/NSS.S340944. eCollection 2022. Nat Sci Sleep. 2022. PMID: 36325278 Free PMC article. Review.
-
Factors contributing to U.S. parents' decisions to administer melatonin to children.Sleep Med. 2024 Feb;114:49-54. doi: 10.1016/j.sleep.2023.12.018. Epub 2023 Dec 22. Sleep Med. 2024. PMID: 38154149 Free PMC article.
References
-
- Carter MD, Juurlink DN. Five things to know about melatonin. Can Med Assoc J. 2012;184:1923. - PubMed
-
- Brayfield A, editor. Martindale the complete drug reference. 28th ed. London: Pharmaceutcial Press; 2014. Melatonin; pp. 2551–2.
-
- Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev. 2005;9:25–39. - PubMed
-
- The Therapeutic Goods Administration. The Poisons Standard (the SUSMP) [Accessed April 1, 2014]. http://www.tga.gov.au/industry/scheduling-poisons-standard.htm.
-
- Rossi S, editor. Australian Medicines Handbook. Adelaide, SA: AMH Pty Ltd; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical